Themis Medicare Intrinsic Value
Themis Medicare (THEMISMED) median intrinsic value is ₹284.75 from 4 valuation models (range ₹89–₹285), vs current price ₹113.90 — +150.0% upside (Trading Below Calculated Value), margin of safety 60.0%. Browse THEMISMED balance sheet details for revenue, profit, balance sheet and cash flow data.
THEMISMED Valuation Methods Summary — DCF, Graham Number & P/E
Themis Medicare intrinsic value across 4 models vs current price ₹113.90 — upside/downside and value range per method. Also explore Themis Medicare stock price data download to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹284.75 | ₹256.28 - ₹313.23 | +150.0% | Book Value/Share: ₹447.78, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹227.80 | ₹205.02 - ₹250.58 | +100.0% | Revenue/Share: ₹368.89, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹88.89 | ₹80.00 - ₹97.78 | -22.0% | EBITDA: ₹8.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹284.75 | ₹227.80 - ₹341.70 | +150.0% | CF Growth: 5.0%, Discount: 15% |
THEMISMED Intrinsic Value vs Market Price — All Valuation Models
Themis Medicare fair value range ₹89–₹285 vs current market price ₹113.90 across 4 valuation models. For current market price and key ratios, visit Themis Medicare share price chart.
THEMISMED Intrinsic Value Analysis — Undervalued or Overvalued?
Themis Medicare median intrinsic value ₹284.75, current price ₹113.90 — Trading Below Calculated Value by 150.0%, margin of safety 60.0%.
What is the intrinsic value of THEMISMED?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Themis Medicare (THEMISMED) is ₹284.75 (median value). With the current market price of ₹113.90, this represents a +150.0% variance from our estimated fair value.
The valuation range spans from ₹88.89 to ₹284.75, indicating ₹88.89 - ₹284.75.
Is THEMISMED undervalued or overvalued?
Based on our multi-method analysis, Themis Medicare (THEMISMED) appears to be trading below calculated value by approximately 150.0%.
THEMISMED Financial Health — Key Ratios vs Industry Benchmarks
Themis Medicare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 10.48 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -4.0% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -4.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.56x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
THEMISMED Cash Flow Quality — Operating & Free Cash Flow
Themis Medicare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹35 Cr | ₹29 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹22 Cr | ₹14 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹16 Cr | ₹4 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹34 Cr | ₹26 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹57 Cr | ₹49 Cr | Positive Free Cash Flow | 8/10 |